Recombinant Allergens – Production Methods and Use in Molecular Diagnosis and Allergen Immunotherapy

Alergologia ◽  
2020 ◽  
Vol 1 (4) ◽  
pp. 10
Author(s):  
Maria Roxana Buzan ◽  
Manuela Grijincu ◽  
Lauriana-Eunice Zbîrcea ◽  
Laura Haidar ◽  
Carmen Bunu-Panaitescu
2019 ◽  
Vol 47 (3) ◽  
pp. 309-310
Author(s):  
S. Barberi ◽  
G. Traina ◽  
M. Landi ◽  
G. De Castro ◽  
D. Peroni ◽  
...  

2017 ◽  
Vol 158 (23) ◽  
pp. 895-899
Author(s):  
László Endre

Abstract: The only causal treatment for the allergic diseases is the allergen immunotherapy. Besides oral and injection forms, an epicutaneous form is known as well. During the immunization process the use of an adjuvant material is advisable besides the allergen. That adjuvant material can be (besides of the aluminium hydroxid and tyrosine) a bacterial toxin, too. In idealistic circumstances we can substitute the native allergen with its recombinant variant, which could keep its immunogenicity but had lost the allergenicity. In the future the recommended therapy could be the safe, painless, epicutaneous hyposensitization, with recombinant allergens, with bacterial toxin as adjuvants. Orv Hetil. 2017; 158(23): 895–899.


2019 ◽  
Vol 143 (3) ◽  
pp. 831-843 ◽  
Author(s):  
Paolo Maria Matricardi ◽  
Stephanie Dramburg ◽  
Ekaterina Potapova ◽  
Chrysanthi Skevaki ◽  
Harald Renz

Allergy ◽  
2014 ◽  
Vol 69 (10) ◽  
pp. 1357-1363 ◽  
Author(s):  
C. Moreno ◽  
J. L. Justicia ◽  
J. Quiralte ◽  
Á. Moreno-Ancillo ◽  
A. Iglesias-Cadarso ◽  
...  

2020 ◽  
Vol 13 (8) ◽  
pp. 100143
Author(s):  
Teresa Garriga-Baraut ◽  
Moisés Labrador-Horrillo ◽  
Giovanna Araujo ◽  
Miguel A. Baltasar-Dragó ◽  
Maria Basagaña-Torrento ◽  
...  

Author(s):  
Domingo Barber Hernández ◽  
Araceli Diaz Perales ◽  
Maria Escribese ◽  
Jörg Kleine-Tebbe ◽  
Paolo Matricardi ◽  
...  

Progressive knowledge of allergenic structures resulted in a broad availability of allergenic molecules for diagnosis. Component resolved diagnosis allowed a better understanding of patient sensitization patterns, facilitating allergen immunotherapy decisions. In parallel to the discovery of allergenic molecules, there was a progressive development of a regulation framework that affected both in vitro diagnostics and Allergen Immunotherapy products. With a progressive understanding of underlying mechanisms associated to Allergen immunotherapy and an increasing experience of application of molecular diagnosis in daily life, we focus in analyzing the evidences of the value provided by molecular allergology in daily clinical practice, with a focus on Allergen Immunotherapy decissions.


2006 ◽  
Vol 175 (4S) ◽  
pp. 485-486
Author(s):  
Sabarinath B. Nair ◽  
Christodoulos Pipinikas ◽  
Roger Kirby ◽  
Nick Carter ◽  
Christiane Fenske

Author(s):  
Wayne Thomas ◽  
Wendy-Anne Smith ◽  
Belinda Hales

Sign in / Sign up

Export Citation Format

Share Document